Herceptin-话题@MedSci

#Herceptin#

7篇内容 | 725人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1548182, encodeId=eb9d1548182b3, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=辉瑞Trazimera（Herceptin生物仿制药）已获欧盟委员会的批准, objectType=article, longId=145635, objectId=848014563563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=848014563563, replyNumber=0, likeNumber=38, createdTime=2018-08-03, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=848014563563, moduleTitle=辉瑞Trazimera（Herceptin生物仿制药）已获欧盟委员会的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=848014563563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548181, encodeId=9bf5154818151, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=欧洲推出Herceptin生物仿制药Herzuma, objectType=article, longId=137306, objectId=3a5a13e306c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a5a13e306c6, replyNumber=0, likeNumber=40, createdTime=2018-05-06, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a5a13e306c6, moduleTitle=欧洲推出Herceptin生物仿制药Herzuma, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a5a13e306c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548180, encodeId=e6a015481800a, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=美国拒绝罗氏Rituxan和Herceptin生物仿制药的申请, objectType=article, longId=134432, objectId=34851344321d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34851344321d, replyNumber=0, likeNumber=28, createdTime=2018-04-08, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34851344321d, moduleTitle=美国拒绝罗氏Rituxan和Herceptin生物仿制药的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34851344321d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548179, encodeId=d97315481e9f9, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=美国批准Herceptin生物仿制药, objectType=article, longId=122314, objectId=33e712231494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e712231494, replyNumber=0, likeNumber=44, createdTime=2017-12-06, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e712231494, moduleTitle=美国批准Herceptin生物仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e712231494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548178, encodeId=7f1215481e8d8, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌, objectType=article, longId=20872, objectId=597b208e219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597b208e219, replyNumber=0, likeNumber=36, createdTime=2013-07-05, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597b208e219, moduleTitle=CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597b208e219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548177, encodeId=327215481e78a, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据, objectType=article, longId=5761, objectId=6ea85e6117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea85e6117, replyNumber=0, likeNumber=35, createdTime=2012-04-27, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea85e6117, moduleTitle=罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea85e6117)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548176, encodeId=1c8b15481e67c, content=<a href='/topic/show?id=48b98e537f' target=_blank style='color:#2F92EE;'>#Herceptin#</a>, objectTitle=Herceptin 在HER2+乳腺癌的辅助和新辅助治疗, objectType=article, longId=3291, objectId=7fa03291fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa03291fe, replyNumber=0, likeNumber=36, createdTime=2011-11-14, rootId=0, userName=minhuang75_72521588, userId=5ecc14021123, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa03291fe, moduleTitle=Herceptin 在HER2+乳腺癌的辅助和新辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa03291fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Herceptin

2020-05-29

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

辉瑞Trazimera（Herceptin生物仿制药）已获欧盟委员会的批准

2018-08-03

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

欧洲推出Herceptin生物仿制药Herzuma

2018-05-06

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

美国拒绝罗氏Rituxan和Herceptin生物仿制药的申请

2018-04-08

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

美国批准Herceptin生物仿制药

2017-12-06

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

CHMP建议批准罗氏皮下注射剂型Herceptin用于HER2阳性乳腺癌

2013-07-05

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

罗氏（Roche）公布Herceptin皮下注射剂型III期研究数据

2012-04-27

minhuang75_72521588 (审核中...)

前往app查看评论内容

#Herceptin#

Herceptin 在HER2+乳腺癌的辅助和新辅助治疗

2011-11-14

科室
- - 订阅+
  - 更多科室
工具
服务